Pediatrics
Feature
COVID emergency orders ending: What’s next?
There will be cost-sharing changes for COVID-19 vaccines, testing, and certain treatments.
Latest News
Expert offers insights on pediatric dermatology emergencies
Antiepileptic medications are the most common cause of DRESS, followed by antibiotics, but sometimes the trigger is not clear.
Case Letter
Hemorrhagic Lacrimation and Epistaxis: Rare Findings in Acute Hemorrhagic Edema of Infancy
Hemorrhagic lacrimation and epistaxis are dramatic presentations with a narrow differential diagnosis.
Commentary
75 years: A look back on the fascinating history of methotrexate and folate antagonists
Dr. David Warmflash recounts how the meandering path of early research into chemotherapy for hematologic malignancies later led to methotrexate’s...
Pediatric Dermatology Consult
A toddler presents with a dark line on a fingernail
A 2-year-old boy presents with a dark band across a fingernail.
Latest News
AD outcomes improved with lebrikizumab and topical steroids
The percentage of patients who achieved the combined endpoint was more than double for the lebrikizumab plus TCS group vs. the group on TCS alone...
Latest News
Study spotlights clinicopathologic features, survival outcomes of pediatric melanoma
The median Breslow thickness was 2.7 mm in children and 1.0 mm in adolescents.
Latest News
Infantile hemangioma: Analysis underscores importance of early propranolol treatment
Ideally, infants should be examined by a practitioner between 2 and 5 weeks of age and referred to a specialized center if they have features of...
Latest News
Berdazimer gel under review at FDA for treating molluscum contagiosum
A 3.4% formulation is in development for the topical treatment of acne.
Photo Challenge
Hyperpigmented Papules on the Tongue of a Child
A 9-year-old Black boy presented to the dermatology clinic for evaluation of dark spots on the tongue. The family first noted these spots 5 months...
Latest News
Topical treatment options for acne continue to expand
IDP-126 is a fixed dose triple combination of clindamycin 1.2% plus benzoyl peroxide 3.1% and adapalene 0.15% is being evaluated in patients nine...